clinical trials

Looking to cement its lead in packed MS market, Roche's Ocrevus uncorks new data in early-stage patients
Looking to cement its lead in packed MS market, Roche's Ocrevus uncorks new data in early-stage patients
Endpoints
Roche
Ocrevus
MS
multiple sclerosis
clinical trials
Flag link:
Amylyx Pharma’s ALS drug needs a Phase 3 study to support FDA submission
Amylyx Pharma’s ALS drug needs a Phase 3 study to support FDA submission
MedCity News
Amylyx
ALS
clinical trials
FDA
Flag link:
Romark eyes FDA okay for COVID antiviral despite mixed trial results
Romark eyes FDA okay for COVID antiviral despite mixed trial results
Pharmaforum
Romark
antivirals
NT-300
clinical trials
COVID-19
Flag link:
GSK stops Keytruda combo trials after ICOS drug falls short
GSK stops Keytruda combo trials after ICOS drug falls short
Fierce Biotech
GSK
feladilimab
Keytruda
clinical trials
ICOS
Flag link:
Merck cans one COVID-19 drug, scraps a clinical trial of another
Merck cans one COVID-19 drug, scraps a clinical trial of another
Fierce Biotech
Merck
COVID-19
MK-7110
OncoImmune
clinical trials
Flag link:
Sponsors should flag decentralized aspects of cancer trials to prep for the post-Covid era, FDA says
Sponsors should flag decentralized aspects of cancer trials to prep for the post-Covid era, FDA says
Endpoints
FDA
oncology
clinical trials
decentralized clinical trials
Flag link:
Moderna and Novavax added to ‘mix and match’ COVID-19 vaccine trial
Moderna and Novavax added to ‘mix and match’ COVID-19 vaccine trial
Marketwatch
vaccines
COVID-19
Moderna Therapeutics
Novavax
AstraZeneca
Pfizer
BioNTech
clinical trials
Flag link:
Nearly a year after Audentes' gene therapy deaths, the trial continues. What happened remains a mystery
Nearly a year after Audentes' gene therapy deaths, the trial continues. What happened remains a mystery
Endpoints
Audentes
Astellas
gene therapy
clinical trials
Flag link:
Pfizer/Myovant take relugolix contraceptive combination pill into phase 3
Pfizer/Myovant take relugolix contraceptive combination pill into phase 3
Pharmaforum
Pfizer
Myovant
Relugolix
contraceptives
clinical trials
Flag link:
ASCO-Friends meeting: NCI offers strategies to modernize cancer trials
ASCO-Friends meeting: NCI offers strategies to modernize cancer trials
RAPS.org
ASCO
cancer
clinical trials
Flag link:
Gilead stops Veklury study, citing enrollment challenges, changing treatment
Gilead stops Veklury study, citing enrollment challenges, changing treatment
BioPharma Dive
Gilead Sciences
COVID-19
remdesivir
Veklury
clinical trials
Flag link:
Cell and gene therapy services market forecast to see significant growth over the next decade
Cell and gene therapy services market forecast to see significant growth over the next decade
Biopharma Reporter
cell therapy
gene therapy
clinical trials
Flag link:
Sage, Biogen's tremor drug hits goal, but 38% of people drop out
Sage, Biogen's tremor drug hits goal, but 38% of people drop out
Fierce Biotech
SAGE Therapeutics
Biogen
essential tremor
SAGE-324
side effects
clinical trials
Flag link:
AACR 2021 – Affimed wins, Oncternal loses
AACR 2021 – Affimed wins, Oncternal loses
EP Vantage
AACR
Affimed
AFM13
Oncternal
clinical trials
Flag link:
AstraZeneca’s Farxiga fails phase 3 COVID-19 test
AstraZeneca’s Farxiga fails phase 3 COVID-19 test
Pharmaforum
AstraZeneca
diabetes
heart failure
Farxiga
COVID-19
clinical trials
Flag link:
Lilly gene-targeted drug shows potential for use across cancers
Lilly gene-targeted drug shows potential for use across cancers
BioPharma Dive
Eli Lilly
AAACR
Retevmo
cancer
clinical trials
Flag link:
Sanofi drops 'intriguing' data on rival to Bristol Myers' bempeg
Sanofi drops 'intriguing' data on rival to Bristol Myers' bempeg
Fierce Biotech
Sanofi
solid tumors
Bristol Myers Squibb
Nektar Therapeutics
Synthorx
clinical trials
Flag link:
Merck's Keytruda, on the heels of a first-line kidney cancer win, targets earlier, post-surgery use
Merck's Keytruda, on the heels of a first-line kidney cancer win, targets earlier, post-surgery use
Fierce Pharma
Merck
Keytruda
renal cell carcinoma
kidney cancer
clinical trials
Flag link:
Bristol Myers' Opdivo notches a double win against chemo in esophageal cancer, potentially setting up 1st-line nod
Bristol Myers' Opdivo notches a double win against chemo in esophageal cancer, potentially setting up 1st-line nod
Endpoints
Bristol Myers Squibb
Opdivo
clinical trials
esophageal cancer
Flag link:
Valneva takes COVID-19 vaccine candidate into Phase 3 trials
Valneva takes COVID-19 vaccine candidate into Phase 3 trials
Biopharma Reporter
Valneva
COVID-19
vaccines
clinical trials
Flag link:

Pages